Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FS2KL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,262
Award facts
- Contract value 100% obligated
- $68,262.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with a ceiling value of $68,262.01. This competitively awarded delivery order, valued at firm fixed price, represents a continuation of pharmaceutical support services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract contains no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 16, 2025.
Zepbound is a GLP-1 receptor agonist used for weight management treatment, and this delivery order fulfills federal healthcare procurement needs for the military and veteran healthcare systems served by the Defense Health Agency and related government entities. As a major pharmaceutical distributor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The award reflects the company's demonstrated capability to meet federal medical procurement requirements through open competition and supports DLA's strategic objective of maintaining robust pharmaceutical supply chains for defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FS2KL?
SPE2DB26FS2KL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 15, 2025.
How much is contract SPE2DB26FS2KL worth?
The government has obligated $68,262 on SPE2DB26FS2KL.
Is contract SPE2DB26FS2KL an order under another contract?
Yes. SPE2DB26FS2KL is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB26FS2KL competed?
The extent of competition for SPE2DB26FS2KL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award